| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidyltransferase activity | 3.68e-10 | 6 | 46 | 4 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 3.68e-10 | 6 | 46 | 4 | GO:0002951 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 1.71e-09 | 8 | 46 | 4 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 3.08e-09 | 9 | 46 | 4 | GO:0036374 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 4.40e-08 | 16 | 46 | 4 | GO:0008242 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 1.16e-07 | 20 | 46 | 4 | GO:0070003 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 3.78e-05 | 82 | 46 | 4 | GO:1990756 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 6.73e-05 | 95 | 46 | 4 | GO:0140767 | |
| GeneOntologyMolecularFunction | transcription elongation factor activity | 1.85e-04 | 9 | 46 | 2 | GO:0003711 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 1.99e-04 | 532 | 46 | 7 | GO:0016755 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a tRNA | 3.35e-04 | 144 | 46 | 4 | GO:0140101 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 3.50e-04 | 775 | 46 | 8 | GO:0016746 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 2.17e-03 | 30 | 46 | 2 | GO:0097472 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 2.17e-03 | 30 | 46 | 2 | GO:0004693 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 4.59e-03 | 1160 | 46 | 8 | GO:0030674 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 7.13e-03 | 55 | 46 | 2 | GO:0042974 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 4.50e-09 | 10 | 46 | 4 | GO:1901750 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 7.06e-09 | 11 | 46 | 4 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 1.06e-08 | 12 | 46 | 4 | GO:1901748 | |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 1.02e-07 | 20 | 46 | 4 | GO:0006750 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 1.54e-07 | 22 | 46 | 4 | GO:0019370 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 1.54e-07 | 22 | 46 | 4 | GO:0019184 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 5.77e-07 | 8 | 46 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 9.56e-07 | 34 | 46 | 4 | GO:0043043 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 1.06e-06 | 82 | 46 | 5 | GO:1901568 | |
| GeneOntologyBiologicalProcess | peptide modification | 1.23e-06 | 10 | 46 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | modified amino acid catabolic process | 1.35e-06 | 37 | 46 | 4 | GO:0042219 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 2.06e-06 | 41 | 46 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | fatty acid derivative biosynthetic process | 5.42e-06 | 52 | 46 | 4 | GO:1901570 | |
| GeneOntologyBiologicalProcess | modified amino acid biosynthetic process | 5.42e-06 | 52 | 46 | 4 | GO:0042398 | |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 5.70e-06 | 16 | 46 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | sulfur compound catabolic process | 5.85e-06 | 53 | 46 | 4 | GO:0044273 | |
| GeneOntologyBiologicalProcess | glutathione metabolic process | 1.17e-05 | 63 | 46 | 4 | GO:0006749 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 1.34e-05 | 21 | 46 | 3 | GO:0000097 | |
| GeneOntologyBiologicalProcess | negative regulation of hypoxia-inducible factor-1alpha signaling pathway | 1.46e-05 | 3 | 46 | 2 | GO:1902072 | |
| GeneOntologyBiologicalProcess | icosanoid biosynthetic process | 1.50e-05 | 67 | 46 | 4 | GO:0046456 | |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 2.31e-05 | 25 | 46 | 3 | GO:0009070 | |
| GeneOntologyBiologicalProcess | regulation of hypoxia-inducible factor-1alpha signaling pathway | 2.91e-05 | 4 | 46 | 2 | GO:1902071 | |
| GeneOntologyBiologicalProcess | homeostasis of number of retina cells | 2.91e-05 | 4 | 46 | 2 | GO:0048877 | |
| GeneOntologyBiologicalProcess | melanin metabolic process | 3.64e-05 | 29 | 46 | 3 | GO:0006582 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 3.67e-05 | 84 | 46 | 4 | GO:0006518 | |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 3.95e-05 | 172 | 46 | 5 | GO:0043604 | |
| GeneOntologyBiologicalProcess | sulfur compound biosynthetic process | 4.66e-05 | 178 | 46 | 5 | GO:0044272 | |
| GeneOntologyBiologicalProcess | ciliary body morphogenesis | 7.26e-05 | 6 | 46 | 2 | GO:0061073 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 9.68e-05 | 40 | 46 | 3 | GO:0000096 | |
| GeneOntologyBiologicalProcess | serine family amino acid metabolic process | 1.20e-04 | 43 | 46 | 3 | GO:0009069 | |
| GeneOntologyBiologicalProcess | modified amino acid metabolic process | 1.21e-04 | 218 | 46 | 5 | GO:0006575 | |
| GeneOntologyBiologicalProcess | hypoxia-inducible factor-1alpha signaling pathway | 1.73e-04 | 9 | 46 | 2 | GO:0097411 | |
| GeneOntologyBiologicalProcess | eye pigmentation | 2.16e-04 | 10 | 46 | 2 | GO:0048069 | |
| GeneOntologyBiologicalProcess | regulation protein catabolic process at postsynapse | 2.16e-04 | 10 | 46 | 2 | GO:0140252 | |
| GeneOntologyBiologicalProcess | iris morphogenesis | 2.64e-04 | 11 | 46 | 2 | GO:0061072 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 2.81e-04 | 142 | 46 | 4 | GO:0006690 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 2.81e-04 | 142 | 46 | 4 | GO:0018958 | |
| GeneOntologyBiologicalProcess | developmental pigmentation | 2.94e-04 | 58 | 46 | 3 | GO:0048066 | |
| GeneOntologyBiologicalProcess | negative regulation of thymocyte apoptotic process | 3.74e-04 | 13 | 46 | 2 | GO:0070244 | |
| GeneOntologyBiologicalProcess | pancreatic A cell differentiation | 4.35e-04 | 14 | 46 | 2 | GO:0003310 | |
| GeneOntologyBiologicalProcess | regulation protein catabolic process at synapse | 4.35e-04 | 14 | 46 | 2 | GO:0140250 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 4.50e-04 | 67 | 46 | 3 | GO:0019748 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid biosynthetic process | 4.91e-04 | 69 | 46 | 3 | GO:0170038 | |
| GeneOntologyBiologicalProcess | negative regulation of endothelial cell differentiation | 5.02e-04 | 15 | 46 | 2 | GO:0045602 | |
| GeneOntologyBiologicalProcess | L-amino acid biosynthetic process | 5.12e-04 | 70 | 46 | 3 | GO:0170034 | |
| GeneOntologyBiologicalProcess | alpha-amino acid biosynthetic process | 6.77e-04 | 77 | 46 | 3 | GO:1901607 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to hypoxia | 7.28e-04 | 18 | 46 | 2 | GO:1900038 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid metabolic process | 7.62e-04 | 185 | 46 | 4 | GO:0170039 | |
| GeneOntologyBiologicalProcess | amino acid metabolic process | 8.37e-04 | 332 | 46 | 5 | GO:0006520 | |
| GeneOntologyBiologicalProcess | regulation of thymocyte apoptotic process | 9.01e-04 | 20 | 46 | 2 | GO:0070243 | |
| GeneOntologyBiologicalProcess | amino acid biosynthetic process | 9.33e-04 | 86 | 46 | 3 | GO:0008652 | |
| GeneOntologyBiologicalProcess | L-amino acid metabolic process | 1.18e-03 | 208 | 46 | 4 | GO:0170033 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 1.21e-03 | 94 | 46 | 3 | GO:0042440 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | 1.28e-03 | 365 | 46 | 5 | GO:0006790 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine metabolic process | 1.53e-03 | 26 | 46 | 2 | GO:0042069 | |
| GeneOntologyBiologicalProcess | thymocyte apoptotic process | 1.65e-03 | 27 | 46 | 2 | GO:0070242 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to hypoxia | 1.90e-03 | 29 | 46 | 2 | GO:1900037 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell apoptotic process | 2.31e-03 | 32 | 46 | 2 | GO:0070233 | |
| GeneOntologyBiologicalProcess | alpha-amino acid metabolic process | 2.34e-03 | 251 | 46 | 4 | GO:1901605 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 2.49e-03 | 121 | 46 | 3 | GO:0006576 | |
| GeneOntologyBiologicalProcess | pigmentation | 2.73e-03 | 125 | 46 | 3 | GO:0043473 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 3.41e-06 | 47 | 46 | 4 | GO:0031462 | |
| GeneOntologyCellularComponent | CKM complex | 4.72e-05 | 5 | 46 | 2 | GO:1990508 | |
| GeneOntologyCellularComponent | VCB complex | 1.32e-04 | 8 | 46 | 2 | GO:0030891 | |
| GeneOntologyCellularComponent | cytoplasmic ubiquitin ligase complex | 4.24e-04 | 14 | 46 | 2 | GO:0000153 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 7.09e-04 | 18 | 46 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | 1.02e-03 | 352 | 46 | 5 | GO:0000151 | |
| GeneOntologyCellularComponent | transferase complex | 1.08e-03 | 963 | 46 | 8 | GO:1990234 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 1.20e-03 | 212 | 46 | 4 | GO:0031461 | |
| MousePheno | abnormal circulating glutathione level | 1.56e-07 | 5 | 36 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 1.56e-07 | 5 | 36 | 3 | MP:0030653 | |
| MousePheno | increased glutathione level | 1.56e-07 | 5 | 36 | 3 | MP:0012606 | |
| MousePheno | glutathionuria | 1.56e-07 | 5 | 36 | 3 | MP:0013730 | |
| MousePheno | decreased circulating cysteine level | 5.45e-07 | 7 | 36 | 3 | MP:0030626 | |
| MousePheno | epididymis hypoplasia | 8.71e-07 | 8 | 36 | 3 | MP:0004932 | |
| MousePheno | decreased cysteine level | 8.71e-07 | 8 | 36 | 3 | MP:0030623 | |
| MousePheno | nervous | 1.30e-06 | 9 | 36 | 3 | MP:0008912 | |
| MousePheno | failure of copulatory plug deposition | 1.86e-06 | 10 | 36 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 1.86e-06 | 10 | 36 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 1.86e-06 | 10 | 36 | 3 | MP:0005158 | |
| MousePheno | abnormal circulating cysteine level | 2.55e-06 | 11 | 36 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 2.55e-06 | 11 | 36 | 3 | MP:0011130 | |
| MousePheno | infertility | LRRC56 DUOX2 TYRP1 PRAMEF33 PRAMEF10 MEI1 NUTM2F INSL6 GGT2P GGT1 NUTM2G GGT3P PKD1 | 4.08e-06 | 1188 | 36 | 13 | MP:0001924 |
| MousePheno | abnormal cysteine level | 4.41e-06 | 13 | 36 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 4.41e-06 | 13 | 36 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 4.41e-06 | 13 | 36 | 3 | MP:0012603 | |
| MousePheno | priapism | 5.60e-06 | 14 | 36 | 3 | MP:0003415 | |
| MousePheno | decreased thyroxine level | 8.49e-06 | 51 | 36 | 4 | MP:0005471 | |
| MousePheno | abnormal spleen red pulp morphology | 8.55e-06 | 110 | 36 | 5 | MP:0002356 | |
| MousePheno | abnormal copulatory plug deposition | 8.58e-06 | 16 | 36 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 8.58e-06 | 16 | 36 | 3 | MP:0008477 | |
| MousePheno | failure of superovulation | 1.25e-05 | 18 | 36 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 1.25e-05 | 18 | 36 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 1.25e-05 | 18 | 36 | 3 | MP:0009093 | |
| MousePheno | disproportionate dwarf | 1.33e-05 | 57 | 36 | 4 | MP:0002427 | |
| MousePheno | abnormal copulation physiology | 1.48e-05 | 19 | 36 | 3 | MP:0031627 | |
| MousePheno | increased circulating growth hormone level | 1.48e-05 | 19 | 36 | 3 | MP:0005123 | |
| MousePheno | male infertility | LRRC56 TYRP1 PRAMEF33 PRAMEF10 MEI1 NUTM2F INSL6 GGT2P GGT1 NUTM2G GGT3P | 1.57e-05 | 944 | 36 | 11 | MP:0001925 |
| MousePheno | decreased circulating insulin-like growth factor I level | 1.74e-05 | 61 | 36 | 4 | MP:0004701 | |
| MousePheno | diluted coat color | 2.11e-05 | 64 | 36 | 4 | MP:0000371 | |
| MousePheno | abnormal sperm number | 2.12e-05 | 624 | 36 | 9 | MP:0002673 | |
| MousePheno | small vertebrae | 2.34e-05 | 22 | 36 | 3 | MP:0004610 | |
| MousePheno | abnormal thyroxine level | 2.38e-05 | 66 | 36 | 4 | MP:0005469 | |
| MousePheno | decreased male germ cell number | 2.59e-05 | 640 | 36 | 9 | MP:0004901 | |
| MousePheno | increased growth hormone level | 2.68e-05 | 23 | 36 | 3 | MP:0005137 | |
| MousePheno | uterus hypoplasia | 2.68e-05 | 23 | 36 | 3 | MP:0001121 | |
| MousePheno | abnormal copulation behavior | 3.06e-05 | 24 | 36 | 3 | MP:0009697 | |
| MousePheno | abnormal circulating insulin-like growth factor I level | 3.36e-05 | 72 | 36 | 4 | MP:0004700 | |
| MousePheno | abnormal thyroid hormone level | 3.75e-05 | 74 | 36 | 4 | MP:0005468 | |
| MousePheno | nuclear cataract | 3.92e-05 | 26 | 36 | 3 | MP:0010254 | |
| MousePheno | abnormal insulin-like growth factor I level | 3.95e-05 | 75 | 36 | 4 | MP:0008831 | |
| MousePheno | decreased germ cell number | 4.51e-05 | 687 | 36 | 9 | MP:0002209 | |
| MousePheno | hindlimb paralysis | 4.85e-05 | 79 | 36 | 4 | MP:0000755 | |
| MousePheno | aminoaciduria | 5.47e-05 | 29 | 36 | 3 | MP:0003311 | |
| MousePheno | limb paralysis | 5.89e-05 | 83 | 36 | 4 | MP:0013147 | |
| MousePheno | anovulation | 8.12e-05 | 33 | 36 | 3 | MP:0008869 | |
| MousePheno | decreased circulating follicle stimulating hormone level | 8.89e-05 | 34 | 36 | 3 | MP:0002790 | |
| MousePheno | increased hepatic hemangioma incidence | 9.61e-05 | 6 | 36 | 2 | MP:0002047 | |
| MousePheno | decreased amino acid level | 1.08e-04 | 97 | 36 | 4 | MP:0014528 | |
| MousePheno | abnormal skeleton development | 1.22e-04 | 447 | 36 | 7 | MP:0002113 | |
| MousePheno | decreased bone mass | 1.22e-04 | 100 | 36 | 4 | MP:0004016 | |
| MousePheno | decreased circulating estradiol level | 1.24e-04 | 38 | 36 | 3 | MP:0005181 | |
| MousePheno | kidney cortex cyst | 1.24e-04 | 38 | 36 | 3 | MP:0000522 | |
| MousePheno | abnormal gametes | 1.27e-04 | 785 | 36 | 9 | MP:0001124 | |
| MousePheno | increased activity of parathyroid | 1.34e-04 | 7 | 36 | 2 | MP:0003432 | |
| MousePheno | decreased tertiary ovarian follicle number | 1.35e-04 | 39 | 36 | 3 | MP:0011129 | |
| MousePheno | decreased circulating estrogen level | 1.56e-04 | 41 | 36 | 3 | MP:0003371 | |
| MousePheno | induced hyperactivity | 1.68e-04 | 42 | 36 | 3 | MP:0008911 | |
| MousePheno | increased circulating pituitary hormone level | 1.76e-04 | 110 | 36 | 4 | MP:0005117 | |
| MousePheno | abnormal parathyroid gland physiology | 1.79e-04 | 8 | 36 | 2 | MP:0003431 | |
| MousePheno | decreased follicle stimulating hormone level | 1.93e-04 | 44 | 36 | 3 | MP:0005130 | |
| MousePheno | decreased long bone epiphyseal plate size | 1.93e-04 | 44 | 36 | 3 | MP:0006396 | |
| MousePheno | absent estrous cycle | 1.93e-04 | 44 | 36 | 3 | MP:0009009 | |
| MousePheno | abnormal long bone hypertrophic chondrocyte zone | 1.95e-04 | 113 | 36 | 4 | MP:0000165 | |
| MousePheno | preneoplasia | 2.30e-04 | 9 | 36 | 2 | MP:0002009 | |
| MousePheno | abnormal tertiary ovarian follicle number | 2.35e-04 | 47 | 36 | 3 | MP:0011127 | |
| MousePheno | paralysis | 2.38e-04 | 119 | 36 | 4 | MP:0000753 | |
| MousePheno | abnormal male germ cell morphology | 2.50e-04 | 859 | 36 | 9 | MP:0006362 | |
| MousePheno | abnormal amino acid derivative level | 2.88e-04 | 125 | 36 | 4 | MP:0021145 | |
| MousePheno | short femur | 3.06e-04 | 127 | 36 | 4 | MP:0003109 | |
| MousePheno | increased pituitary hormone level | 3.15e-04 | 128 | 36 | 4 | MP:0003973 | |
| MousePheno | abnormal circulating estradiol level | 3.18e-04 | 52 | 36 | 3 | MP:0005183 | |
| MousePheno | decreased femur size | 3.34e-04 | 130 | 36 | 4 | MP:0030825 | |
| MousePheno | polycythemia | 3.50e-04 | 11 | 36 | 2 | MP:0002872 | |
| MousePheno | abnormal male reproductive system physiology | LRRC56 TYRP1 PRAMEF33 PRAMEF10 MEI1 NUTM2F INSL6 GGT2P GGT1 NUTM2G GGT3P | 3.52e-04 | 1329 | 36 | 11 | MP:0003698 |
| MousePheno | aciduria | 3.75e-04 | 55 | 36 | 3 | MP:0010028 | |
| MousePheno | abnormal spermatogenesis | 3.84e-04 | 910 | 36 | 9 | MP:0001156 | |
| MousePheno | oligozoospermia | 4.00e-04 | 384 | 36 | 6 | MP:0002687 | |
| MousePheno | abnormal circulating estrogen level | 4.17e-04 | 57 | 36 | 3 | MP:0003369 | |
| MousePheno | abnormal tertiary ovarian follicle morphology | 4.17e-04 | 57 | 36 | 3 | MP:0009363 | |
| MousePheno | abnormal growth hormone level | 4.17e-04 | 57 | 36 | 3 | MP:0003968 | |
| MousePheno | abnormal urine amino acid level | 4.62e-04 | 59 | 36 | 3 | MP:0011468 | |
| MousePheno | immotile sperm | 4.62e-04 | 59 | 36 | 3 | MP:0020869 | |
| MousePheno | decreased circulating gonadotropin level | 4.85e-04 | 60 | 36 | 3 | MP:0003363 | |
| MousePheno | decreased circulating testosterone level | 4.85e-04 | 60 | 36 | 3 | MP:0002780 | |
| MousePheno | impaired ovarian folliculogenesis | 5.09e-04 | 61 | 36 | 3 | MP:0001129 | |
| MousePheno | abnormal germ cell morphology | 5.11e-04 | 946 | 36 | 9 | MP:0002208 | |
| MousePheno | abnormal foam cell morphology | 5.43e-04 | 954 | 36 | 9 | MP:0009840 | |
| MousePheno | pulmonary hypertension | 5.75e-04 | 14 | 36 | 2 | MP:0003548 | |
| MousePheno | abnormal superovulation | 6.42e-04 | 66 | 36 | 3 | MP:0009648 | |
| MousePheno | absent corpus luteum | 6.42e-04 | 66 | 36 | 3 | MP:0001134 | |
| MousePheno | increased pulmonary artery pressure | 6.63e-04 | 15 | 36 | 2 | MP:0004012 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 7.01e-04 | 68 | 36 | 3 | MP:0003662 | |
| MousePheno | small epididymis | 7.63e-04 | 70 | 36 | 3 | MP:0004930 | |
| MousePheno | abnormal pulmonary pressure | 8.56e-04 | 17 | 36 | 2 | MP:0003547 | |
| MousePheno | abnormal circulating pituitary hormone level | 9.59e-04 | 172 | 36 | 4 | MP:0005116 | |
| MousePheno | abnormal cartilage development | 9.59e-04 | 172 | 36 | 4 | MP:0000164 | |
| MousePheno | abnormal long bone epiphyseal plate morphology | 9.59e-04 | 172 | 36 | 4 | MP:0003055 | |
| MousePheno | increased osteoclast cell number | 1.01e-03 | 77 | 36 | 3 | MP:0004984 | |
| Domain | GGT_peptidase | 4.24e-07 | 7 | 44 | 3 | IPR000101 | |
| Domain | G_glu_transpept | 4.24e-07 | 7 | 44 | 3 | PF01019 | |
| Domain | G_GLU_TRANSPEPTIDASE | 4.24e-07 | 7 | 44 | 3 | PS00462 | |
| Domain | - | 5.42e-06 | 2 | 44 | 2 | 2.60.40.780 | |
| Domain | VHL | 5.42e-06 | 2 | 44 | 2 | PF01847 | |
| Domain | VHL_beta_dom | 5.42e-06 | 2 | 44 | 2 | IPR024053 | |
| Domain | VHL | 5.42e-06 | 2 | 44 | 2 | IPR002714 | |
| Domain | VHL_tumour_suppress_b/a_dom | 5.42e-06 | 2 | 44 | 2 | IPR022772 | |
| Domain | NUT | 5.40e-05 | 5 | 44 | 2 | IPR024310 | |
| Domain | NUT_N | 5.40e-05 | 5 | 44 | 2 | IPR024309 | |
| Domain | NUT | 5.40e-05 | 5 | 44 | 2 | PF12881 | |
| Domain | Ntn_hydrolases_N | 2.73e-03 | 33 | 44 | 2 | IPR029055 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.59e-09 | 25 | 30 | 5 | MM14858 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 2.98e-08 | 16 | 30 | 4 | MM14680 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.68e-07 | 61 | 30 | 5 | MM14861 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 2.41e-07 | 26 | 30 | 4 | MM15190 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 2.83e-07 | 27 | 30 | 4 | MM15908 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 6.53e-07 | 33 | 30 | 4 | MM15963 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 8.33e-07 | 35 | 30 | 4 | MM15815 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 1.17e-06 | 38 | 30 | 4 | MM14600 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.30e-06 | 39 | 30 | 4 | MM15695 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.13e-05 | 21 | 30 | 3 | M27137 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 1.30e-05 | 22 | 30 | 3 | MM15961 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 1.71e-05 | 24 | 30 | 3 | MM17249 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 2.68e-05 | 170 | 30 | 5 | MM15573 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 4.09e-05 | 92 | 30 | 4 | MM15823 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 7.39e-05 | 107 | 30 | 4 | MM14595 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 8.97e-05 | 219 | 30 | 5 | MM14838 | |
| Pathway | REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION | 9.13e-05 | 7 | 30 | 2 | M29845 | |
| Pathway | REACTOME_DRUG_ADME | 1.12e-04 | 119 | 30 | 4 | MM15692 | |
| Pathway | KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM | 1.95e-04 | 10 | 30 | 2 | M12882 | |
| Pathway | WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE | 2.35e-04 | 57 | 30 | 3 | M48332 | |
| Pathway | REACTOME_RHOBTB3_ATPASE_CYCLE | 2.38e-04 | 11 | 30 | 2 | MM15681 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.61e-04 | 59 | 30 | 3 | M27140 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 2.85e-04 | 12 | 30 | 2 | M27028 | |
| Pathway | WP_LEUKOTRIENE_METABOLIC_PATHWAY | 3.37e-04 | 13 | 30 | 2 | M45552 | |
| Pathway | REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES | 5.84e-04 | 17 | 30 | 2 | MM14829 | |
| Pathway | REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES | 6.56e-04 | 18 | 30 | 2 | M27118 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 7.32e-04 | 19 | 30 | 2 | M27449 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 7.32e-04 | 19 | 30 | 2 | M39388 | |
| Pathway | KEGG_SELENOAMINO_ACID_METABOLISM | 1.38e-03 | 26 | 30 | 2 | M7151 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.72e-03 | 29 | 30 | 2 | M45015 | |
| Pathway | WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321 | 2.35e-03 | 34 | 30 | 2 | M48061 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 2.64e-03 | 36 | 30 | 2 | M1443 | |
| Pubmed | 4.38e-11 | 6 | 47 | 4 | 12163373 | ||
| Pubmed | 4.38e-11 | 6 | 47 | 4 | 11463821 | ||
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 2.31e-09 | 3 | 47 | 3 | 2573352 | |
| Pubmed | 2.90e-09 | 14 | 47 | 4 | 18357469 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 2.31e-08 | 5 | 47 | 3 | 18063838 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 10940879 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 2.31e-08 | 5 | 47 | 3 | 12468440 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 2.31e-08 | 5 | 47 | 3 | 12225953 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 7775425 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 2.31e-08 | 5 | 47 | 3 | 11095909 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 7641802 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 23615310 | ||
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 2.31e-08 | 5 | 47 | 3 | 8566783 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 30591459 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 9139708 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 20622017 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 9627710 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 2.31e-08 | 5 | 47 | 3 | 9546365 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 12453183 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 11795900 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 7485380 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 11003618 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 2.31e-08 | 5 | 47 | 3 | 10751614 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 10392451 | ||
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 2.31e-08 | 5 | 47 | 3 | 7523374 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 2891746 | ||
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 2.31e-08 | 5 | 47 | 3 | 24698228 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 19850887 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 2.31e-08 | 5 | 47 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 2.31e-08 | 5 | 47 | 3 | 19760322 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 10474818 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 2.31e-08 | 5 | 47 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 2.31e-08 | 5 | 47 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 2.31e-08 | 5 | 47 | 3 | 11089562 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 14634009 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 17363454 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 4.61e-08 | 6 | 47 | 3 | 8101000 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 8663190 | ||
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 4.61e-08 | 6 | 47 | 3 | 8104871 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 22242126 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 25326709 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 27775020 | ||
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 8.06e-08 | 7 | 47 | 3 | 1968405 | |
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 8.06e-08 | 7 | 47 | 3 | 32284594 | |
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 36685533 | ||
| Pubmed | 2.09e-07 | 38 | 47 | 4 | 27820600 | ||
| Pubmed | 2.76e-07 | 10 | 47 | 3 | 23863468 | ||
| Pubmed | 3.82e-07 | 44 | 47 | 4 | 16332269 | ||
| Pubmed | 1.02e-06 | 56 | 47 | 4 | 20096683 | ||
| Pubmed | The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism. | 1.04e-06 | 15 | 47 | 3 | 20399150 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 27422990 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19340311 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 10353237 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 37904480 | ||
| Pubmed | Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. | 1.79e-06 | 2 | 47 | 2 | 11171994 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 15908240 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 28574654 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 21925138 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 35250971 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 26488390 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 38618956 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 25180444 | ||
| Pubmed | Mediator kinase inhibition further activates super-enhancer-associated genes in AML. | 1.79e-06 | 2 | 47 | 2 | 26416749 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 28533271 | ||
| Pubmed | Podocytes contribute to the formation of glomerular crescents. | 1.79e-06 | 2 | 47 | 2 | 18199804 | |
| Pubmed | Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. | 1.79e-06 | 2 | 47 | 2 | 8603073 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 18559510 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 14604887 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 32560467 | ||
| Pubmed | Hypoxia and podocyte-specific Vhlh deletion confer risk of glomerular disease. | 1.79e-06 | 2 | 47 | 2 | 17609290 | |
| Pubmed | CDK8/19 Mediator kinases potentiate induction of transcription by NFκB. | 1.79e-06 | 2 | 47 | 2 | 28855340 | |
| Pubmed | The VHL tumor suppressor and HIF: insights from genetic studies in mice. | 1.79e-06 | 2 | 47 | 2 | 18219317 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24999110 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 35181333 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 18957870 | ||
| Pubmed | Comparative sequence analysis of the VHL tumor suppressor gene. | 1.79e-06 | 2 | 47 | 2 | 10857749 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 27436590 | ||
| Pubmed | pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. | 1.79e-06 | 2 | 47 | 2 | 17450132 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 23682772 | ||
| Pubmed | Regulatory functions of the Mediator kinases CDK8 and CDK19. | 1.79e-06 | 2 | 47 | 2 | 30585107 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 21242957 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 7850784 | ||
| Pubmed | Tumor suppressor VHL functions in the control of mitotic fidelity. | 1.79e-06 | 2 | 47 | 2 | 24362914 | |
| Pubmed | Gamma-glutamyl compounds: substrate specificity of gamma-glutamyl transpeptidase enzymes. | 1.79e-06 | 2 | 47 | 2 | 21447318 | |
| Pubmed | A mouse model to study the link between hypoxia, long QT interval and sudden infant death syndrome. | 1.79e-06 | 2 | 47 | 2 | 22977222 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 15899860 | ||
| Pubmed | Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter. | 1.79e-06 | 2 | 47 | 2 | 12114475 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 35118061 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 8521303 | ||
| Pubmed | Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease. | 1.79e-06 | 2 | 47 | 2 | 37833251 | |
| Pubmed | Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function. | 1.79e-06 | 2 | 47 | 2 | 21652636 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 27678455 | ||
| Pubmed | Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch. | 1.79e-06 | 2 | 47 | 2 | 29467323 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 25377544 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 38502859 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 31044597 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 36006697 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 7493907 | ||
| Interaction | GGTLC1 interactions | 5.03e-07 | 8 | 43 | 3 | int:GGTLC1 | |
| Interaction | GGT2P interactions | 1.33e-05 | 3 | 43 | 2 | int:GGT2P | |
| Interaction | GGT1 interactions | 2.01e-05 | 25 | 43 | 3 | int:GGT1 | |
| Interaction | ALCAM interactions | 2.17e-05 | 77 | 43 | 4 | int:ALCAM | |
| Cytoband | 9q22.33 | 5.31e-04 | 33 | 47 | 2 | 9q22.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 8.95e-04 | 419 | 47 | 4 | chr22q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q22 | 1.15e-03 | 200 | 47 | 3 | chr9q22 | |
| Cytoband | 22q11.23 | 1.37e-03 | 53 | 47 | 2 | 22q11.23 | |
| Cytoband | 1p36.21 | 1.93e-03 | 63 | 47 | 2 | 1p36.21 | |
| Cytoband | 19q13.43 | 3.63e-03 | 87 | 47 | 2 | 19q13.43 | |
| Cytoband | 22q11.21 | 5.83e-03 | 111 | 47 | 2 | 22q11.21 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 5.00e-09 | 13 | 31 | 4 | 564 | |
| GeneFamily | Cyclin dependent kinases | 9.01e-04 | 26 | 31 | 2 | 496 | |
| GeneFamily | Cyclins|Mediator complex | 1.45e-03 | 33 | 31 | 2 | 1061 | |
| Drug | 5-hydroxytryptophol | 1.54e-06 | 42 | 46 | 4 | CID000009061 | |
| Drug | gamma-Glutamylglutamate | 8.59e-06 | 20 | 46 | 3 | CID000092865 | |
| Drug | dulofibrate | 1.20e-05 | 3 | 46 | 2 | CID000068812 | |
| Drug | 2-(glutathion-S-yl)hydroquinone | 1.20e-05 | 3 | 46 | 2 | CID000177871 | |
| Drug | Glu-AMC | 1.20e-05 | 3 | 46 | 2 | CID000126296 | |
| Drug | 2-nor-LTD1 | 1.20e-05 | 3 | 46 | 2 | CID006439851 | |
| Drug | gamma-glutamyl-3-carboxy-4-nitroanilide | 1.20e-05 | 3 | 46 | 2 | CID000104545 | |
| Drug | 2-bromo-3-(N-acetylcystein-S-yl)hydroquinone | 1.20e-05 | 3 | 46 | 2 | CID000130861 | |
| Drug | AC1MLYZ1 | 2.39e-05 | 4 | 46 | 2 | CID003277748 | |
| Drug | Agaridoxin | 2.39e-05 | 4 | 46 | 2 | CID000162851 | |
| Drug | formylcolchicine | 2.39e-05 | 4 | 46 | 2 | CID000630944 | |
| Drug | 2-propyltoluene | 2.39e-05 | 4 | 46 | 2 | CID000014091 | |
| Drug | AC1L41R0 | 2.39e-05 | 4 | 46 | 2 | CID000175821 | |
| Drug | beta-aminoglutaryl-L-alpha-aminobutyrate | 2.39e-05 | 4 | 46 | 2 | CID000191734 | |
| Drug | leukotriene C3 | 2.39e-05 | 4 | 46 | 2 | CID005214901 | |
| Drug | Adenylyl Imidodiphosphate | 2.39e-05 | 4 | 46 | 2 | ctd:D000266 | |
| Drug | EHEN | 2.72e-05 | 29 | 46 | 3 | CID000025742 | |
| Drug | glutamylphenylalanine | 3.98e-05 | 5 | 46 | 2 | CID000111299 | |
| Drug | 4-agtp | 3.98e-05 | 5 | 46 | 2 | CID000164283 | |
| Drug | gamma-Glu-gsh | 3.98e-05 | 5 | 46 | 2 | CID000129080 | |
| Drug | 4-hydroxymethylphenylhydrazine | 5.96e-05 | 6 | 46 | 2 | CID000135538 | |
| Drug | GPNA | 5.96e-05 | 6 | 46 | 2 | CID000081732 | |
| Drug | aminocatechol | 5.96e-05 | 6 | 46 | 2 | CID000151726 | |
| Drug | alpha-aminomethylglutarate | 8.33e-05 | 7 | 46 | 2 | CID000191519 | |
| Drug | iosimide | 1.11e-04 | 8 | 46 | 2 | CID000060911 | |
| Drug | cumene | 1.33e-04 | 49 | 46 | 3 | CID000007406 | |
| Drug | Bcdfg | 1.42e-04 | 9 | 46 | 2 | CID003036106 | |
| Drug | Gamma-glutamylglutamine | 1.42e-04 | 9 | 46 | 2 | CID000150914 | |
| Drug | acetaminophen-glutathione | 1.42e-04 | 9 | 46 | 2 | CID000084001 | |
| Drug | Subsporin C | 1.42e-04 | 9 | 46 | 2 | CID000151723 | |
| Drug | 2,3,5-(trigsyl)hq | 1.78e-04 | 10 | 46 | 2 | CID003035059 | |
| Drug | C.I. 337 | 1.78e-04 | 54 | 46 | 3 | CID006331826 | |
| Drug | AC1L2AH8 | 2.17e-04 | 11 | 46 | 2 | CID000017688 | |
| Drug | gludopa | 2.17e-04 | 11 | 46 | 2 | CID000115303 | |
| Drug | tyrosinate | 2.26e-04 | 148 | 46 | 4 | CID000001153 | |
| Drug | phylloerythrin | 3.07e-04 | 13 | 46 | 2 | CID005480977 | |
| Drug | S-oxalylglutathione | 3.07e-04 | 13 | 46 | 2 | CID000168007 | |
| Drug | anthglutin | 3.07e-04 | 13 | 46 | 2 | CID000125748 | |
| Drug | diphenaldehyde | 3.07e-04 | 13 | 46 | 2 | CID000014585 | |
| Drug | sporidesmin | 3.07e-04 | 13 | 46 | 2 | CID000099596 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 1.08e-07 | 7 | 44 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 1.72e-07 | 8 | 44 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | developmental and epileptic encephalopathy 87 (implicated_via_orthology) | 2.17e-06 | 2 | 44 | 2 | DOID:0112221 (implicated_via_orthology) | |
| Disease | von Hippel-Lindau disease (implicated_via_orthology) | 2.17e-06 | 2 | 44 | 2 | DOID:14175 (implicated_via_orthology) | |
| Disease | familial erythrocytosis 2 (implicated_via_orthology) | 2.17e-06 | 2 | 44 | 2 | DOID:0060474 (implicated_via_orthology) | |
| Disease | sudden infant death syndrome (implicated_via_orthology) | 6.51e-06 | 3 | 44 | 2 | DOID:9007 (implicated_via_orthology) | |
| Disease | nephroblastoma (biomarker_via_orthology) | 1.30e-05 | 4 | 44 | 2 | DOID:2154 (biomarker_via_orthology) | |
| Disease | urinary bladder cancer (biomarker_via_orthology) | 1.96e-04 | 14 | 44 | 2 | DOID:11054 (biomarker_via_orthology) | |
| Disease | Carcinoma of Endocrine Gland | 2.25e-04 | 15 | 44 | 2 | C1704374 | |
| Disease | Parkinsonism (implicated_via_orthology) | 8.60e-04 | 29 | 44 | 2 | DOID:0080855 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLFGWIHYRRGLVHL | 166 | A0A0G2JMD5 | |
| YSFRLHIGRNIARPW | 586 | Q15361 | |
| RYHGPDWRIFHRLAL | 31 | A6NF34 | |
| TFWYRAPELLLGARH | 196 | Q9BWU1 | |
| YHKRHLDRPVFLRFW | 501 | Q6P1J9 | |
| WRFLPEALFLHRAFH | 276 | Q92685 | |
| PGREYRALQLHLHWG | 216 | Q16790 | |
| FPPRAHCLVRWYGLR | 111 | Q15042 | |
| WLSLGHPFFYRRHIT | 131 | Q13258 | |
| YPLHYLVWHNRHREL | 16 | Q86YJ7 | |
| YELAHQRHGRLPWAR | 141 | A6NGU5 | |
| RSANWPYGHRRLLRF | 566 | P58215 | |
| ADGRHPRVFAWVYRH | 151 | Q6ZT52 | |
| FKHGIDRYWRRVAPH | 66 | Q9UI26 | |
| RRRSFRGFWLTHHLY | 1211 | Q9NRD8 | |
| ALLFERAHYRHDPRW | 21 | Q5TIA1 | |
| RGKVPGRAHRDWYHR | 26 | Q8WUK0 | |
| VLHLHRREAVRWPYL | 46 | O43559 | |
| GYAEAHRRHGRLPWA | 146 | P36269 | |
| IYWLTPHGRRFLRAC | 236 | P13584 | |
| PWLIHRYRYLGHRFQ | 121 | Q04743 | |
| TFWYRAPELLLGARH | 196 | P49336 | |
| YELAHQRHGRLPWAR | 141 | P36268 | |
| YLHFLEPHTSGWARR | 1581 | Q12756 | |
| LRWRYHALRGELYRP | 4106 | P98161 | |
| YVVGSHHRLRPWRLS | 641 | A1L443 | |
| YVVGSHHRLRPWRLS | 626 | Q5VZR2 | |
| WRYLHHLGSQPAVRR | 141 | Q16613 | |
| RAWREHGVRPLPYRH | 386 | Q8IYG6 | |
| LFWGHHPQRKRRGYS | 161 | Q9Y581 | |
| IHNFRSHPWLFRDAR | 91 | Q6RSH7 | |
| VYHPGHRARAWRFLT | 236 | O75783 | |
| YLGEAHGPWVDLRRR | 61 | Q96CK0 | |
| EGPAFLTWHRYHLLR | 216 | P17643 | |
| LDSPWHRFRRFHLGD | 16 | Q8N0Y2 | |
| HRWYPHGRYHRCRKN | 121 | Q9Y6G3 | |
| DRLVGYPGRLHLWDH | 561 | Q93063 | |
| GRRIHSYRGHLWLFR | 106 | P40337 | |
| AYGHRDRLPALAWLL | 421 | C9JH25 | |
| YLFGWIHYRRGLVHL | 166 | O60809 | |
| GQAFRLGRYPIHWHL | 2466 | Q86WI1 | |
| QFPAHYRRLRHALWP | 516 | P40238 | |
| YWAFHDGQRSRLRPR | 371 | Q14142 | |
| YHQRFGRPRWVDHKD | 371 | E7ETH6 | |
| LFRHWRVHTGVRPYE | 366 | Q6P9A1 | |
| IPGRDHRRYYHDHWR | 96 | C9JLR9 | |
| YELAHQRHGRLPWAR | 141 | P19440 |